Welcome to InfiCure Bio

InfiCure Bio is a life science company focusing on preclinical development and validation of drugs that target chronic inflammatory and fibrotic conditions.

Based on a panel of in vivo models for these conditions including a proprietary model, the NIF mouse, for chronic inflammation and fibrosis, we offer effect tests of anti-inflammatory and anti-fibrotic drugs.

Founded on extensive experience and expertise in immunology, inflammation and fibrosis research, InfiCure Bio offers a proficient and flexible processing of drug validation projects in this area.


We are sorry to announce that InfiCure Bio has closed its operations as of October 2023. If you have any questions regarding the NIF mouse, please contact Sofia Mayans at sofia@mayans.se and she will guide [...]

Visit Innosers NIF poster at Global NASH!

Please take the chance to talk to InnoSer about InfiCure Bio ABs unique NIF mouse model at the 6th NASH Congress! The NIF model spontaneously develops chronic inflammation and fibrosis, which is nicely presented in [...]

Christmas lunch in winter wonderland!

InfiCure Bio enjoyed a traditional Swedish Christmas lunch at beautiful Brännlands Wärdshus. It is hard to find a more Christmasy atmosphere- and the recent snow and cold weather added an extra touch.  We wish you [...]